|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
98,530,000 |
Market
Cap: |
18.88(M) |
Last
Volume: |
78,874 |
Avg
Vol: |
78,659 |
52
Week Range: |
$0.1916 - $0.1916 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
42,758 |
62,758 |
88,758 |
104,627 |
Total Buy Value |
$154,036 |
$241,836 |
$346,094 |
$404,389 |
Total People Bought |
5 |
5 |
5 |
5 |
Total Buy Transactions |
5 |
6 |
9 |
12 |
Total Shares Sold |
0 |
7,084 |
41,479 |
98,636 |
Total Sell Value |
$0 |
$36,199 |
$179,159 |
$193,613 |
Total People Sold |
0 |
1 |
5 |
5 |
Total Sell Transactions |
0 |
1 |
8 |
13 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Alland Leila |
Director |
|
2024-05-16 |
4 |
B |
$4.71 |
$51,799 |
D/D |
11,000 |
82,857 |
2.39 |
- |
|
Charles Faith L. |
Director |
|
2024-04-26 |
4 |
B |
$3.28 |
$24,764 |
D/D |
7,550 |
78,323 |
2.39 |
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2024-04-25 |
4 |
B |
$3.20 |
$32,000 |
D/D |
10,000 |
538,260 |
2.81 |
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2024-04-25 |
4 |
B |
$3.14 |
$17,609 |
D/D |
5,608 |
233,868 |
2.74 |
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2024-04-25 |
4 |
B |
$3.24 |
$27,864 |
D/D |
8,600 |
188,718 |
2.74 |
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2024-03-15 |
4 |
D |
$8.14 |
$5,722 |
D/D |
(703) |
228,260 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2024-03-04 |
4 |
D |
$7.81 |
$1,429 |
D/D |
(183) |
180,118 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2024-02-06 |
4 |
B |
$4.39 |
$87,800 |
D/D |
20,000 |
528,260 |
2.81 |
- |
|
Alvino Mark |
Director |
|
2024-01-17 |
4 |
S |
$5.11 |
$36,199 |
D/D |
(7,084) |
62,816 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2023-10-16 |
4 |
D |
$4.14 |
$749 |
D/D |
(181) |
508,260 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2023-09-29 |
4 |
D |
$3.93 |
$24,484 |
D/D |
(6,230) |
228,963 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2023-09-29 |
4 |
D |
$3.93 |
$52,230 |
D/D |
(13,290) |
508,441 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2023-09-29 |
4 |
D |
$3.93 |
$25,769 |
D/D |
(6,557) |
180,301 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2023-09-27 |
4 |
B |
$4.07 |
$81,400 |
D/D |
20,000 |
521,731 |
2.81 |
- |
|
Silverstein Christine Berni |
Director |
|
2023-09-27 |
4 |
S |
$3.91 |
$24,721 |
D/D |
(6,330) |
87,884 |
|
- |
|
Amoroso Michael |
Director |
|
2023-09-27 |
4 |
S |
$3.91 |
$21,542 |
D/D |
(5,508) |
108,957 |
|
- |
|
Alvino Mark |
Director |
|
2023-09-27 |
4 |
S |
$3.91 |
$24,724 |
D/D |
(6,316) |
69,900 |
|
- |
|
Alland Leila |
Director |
|
2023-09-27 |
4 |
S |
$3.90 |
$28,270 |
D/D |
(7,246) |
71,857 |
|
- |
|
Charles Faith L. |
Director |
|
2023-09-27 |
4 |
S |
$4.91 |
$40,924 |
D/D |
(8,330) |
70,773 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2023-09-21 |
4 |
D |
$3.80 |
$2,139 |
D/D |
(563) |
186,858 |
|
- |
|
Amoroso Michael |
Director |
|
2023-09-20 |
4 |
S |
$3.90 |
$1,275 |
D/D |
(327) |
114,465 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2023-09-19 |
4 |
B |
$3.70 |
$11,458 |
D/D |
3,000 |
238,179 |
2.74 |
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2023-09-18 |
4 |
B |
$3.80 |
$11,400 |
D/D |
3,000 |
187,421 |
2.74 |
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2023-07-24 |
4 |
D |
$3.73 |
$4,428 |
D/D |
(1,187) |
235,179 |
|
- |
|
Gross Phillip |
10% Owner |
|
2023-07-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,249,994 |
|
- |
|
206 Records found
|
|
Page 1 of 9 |
|
|